17 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26316468	53	Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.	University of Arizona
22342268	98	Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships ofa,a-tetrahydropyranylglycine.	Menarini Ricerche
9986712	33	A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.	Institute of Mutagenesis and Differentiation
9484506	49	A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.	Fujisawa Pharmaceutical
9804698	44	A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.	Fujisawa Pharmaceutical
9767643	127	A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.	Fujisawa Pharmaceutical
9767642	76	A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.	Fujisawa Pharmaceutical
7636840	4	Technetium-99m-labeled HOE 140: a potential bradykinin B2 receptor imaging agent.	Zentrale Pharmaforschung
	40	Structure activity relationships of non-peptide bradykinin B2 receptor antagonists	TBA
19552431	104	Novel small molecule bradykinin B2 receptor antagonists.	Jerini
	4	Synthesis and biological activity of new bradykinin pseudopeptide B1 receptor agonists containing alkylic spacers	TBA
10091678	65	Novel series of O-substituted 8-quinolines and 4-benzothiazoles as potent antagonists of the bradykinin B2 receptors.	Hoechst Marion Roussel
31376564	13	Cinnamamide: An insight into the pharmacological advances and structure-activity relationships.	National Institute of Pharmaceutical Education and Research (NIPER)
8394934	9	Design of potent, cyclic peptide bradykinin receptor antagonists from conformationally constrained linear peptides.	Scios Nova
8388469	3	NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal beta-turns.	Scios Nova
7909848	2	A proposed model of bradykinin bound to the rat B2 receptor and its utility for drug design.	Scios Nova